http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S63275351-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33dafb5bbc2ec47ebcb7becbbe60f704 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-051 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3681 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3472 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3486 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36 |
filingDate | 1987-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f65a1905dfcc5f10990761bc245623eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_830dd6a5de905a2c544b282b7df51b83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3b717af2805ddec335af082873b9a06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f0ba9d082f77b4d19cabca171d63eae |
publicationDate | 1988-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-S63275351-A |
titleOfInvention | Blood purifying apparatus |
abstract | PURPOSE: To make the title apparatus adaptable to both of an adult and a newborn, to reduce a side effect and to enhance bilirubin removing efficiency, by applying light irradiation treatment only to blood and plasma containing no blood corpuscle separated by a plasma separation means before performing the adsorbing treatment of bilirubin. n CONSTITUTION: Blood is introduced into a plasma separation means 3 from a blood inlet 1 to be separated into blood whose blood corpuscle is conc. and plasma containing no blood corpuscle. The separated plasma is sent to a light irradiation means 4 and irradiated with light having max. absorption at 400W550nm and substantially containing no ultraviolet rays having a wavelength of 370nm or less. Whereupon, the indirect reacting bilirubin and direct reacting bilirubin contained in the plasma changes to a bilirubin optical isomer. Then, the plasma is sent to an adsorbing treatment means 5 packed with activated carbon and an anion exchange resin to adsorb and remove the bilirubin optical isomer and direct reacting bilirubin. The plasma is sent to a blood and plasma mixing means 6 to be mixed with the concn. blood sent from the plasma separation means 3 and the resulting mixture is sent to a purified blood outlet 7. n COPYRIGHT: (C)1988,JPO&Japio |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101180591-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100393371-C http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0461542-U http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007004593-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007007292-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7998100-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H044934-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7846121-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1481700-A1 |
priorityDate | 1987-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.